Antegrin Therapeutics' Seed VC Round

Antegrin Therapeutics raised a round of funding on October 02, 2015. Investors include iSelect Fund.

Antegrin Therapeutics is a pharmaceutical company dedicated to the development of novel therapies for fibrotic diseases, and offers a robust portfolio of small-molecule integrin antagonists.…

Articles about Antegrin Therapeutics' Seed VC Round: